Health/Medical Research

Applications are invited for research projects on national, state, and/or local policy changes and response to these changes by healthcare systems, insurers, payers, communities, practices, and patients.

Grants will be awarded in support of research proposals to understand pathophysiologic mechanisms that cause the transition from aging to early, dry AMD. If successful, the research will inform the design of targeted treatment for the greatest number of people afflicted with early AMD and prevent blindness from late AMD.

Applications are invited for Angelman syndrome-related research projects.

Grants will be awarded to support early-career scientists engaged in pancreatic cancer research relevant to the goals and mission of the Lustgarten Foundation. This program is to support the development and diversity of talent working in pancreatic cancer research; eligibility is limited to members of racial or ethnic groups that are underrepresented in the cancer-related sciences workforce.

Grants will provide funding to identify a potential microbial link to Alzheimer’s disease. Awards must focus narrowly on elucidating the possible roles of infectious agents in the causation of Alzheimer’s disease. Grants will support innovative research, including basic, clinical, and/or non-traditional approaches. Interdisciplinary research is encouraged, including collaborations between Alzheimer’s research and infectious diseases experts.

Grants will be awarded in support of research with the potential to improve individuals’ health with Alpha-1 antitrypsin deficiency. The program supports basic science and clinical research, improved understanding of the pathogenesis of the clinical manifestations of Alpha-1, the development and testing of treatments for the disease, bioethics, and social research, and the promotion of education of members of the medical community regarding the condition.

Applications are invited for the Innovator Awards Program, which supports basic and translational research and clinical science to advance the understanding of inflammatory bowel disease (IBD).

Grants will be awarded for research projects that advance understanding of the dynamic changes in sleep and circadian rhythm across trajectories and phases of anxiety, depression, and psychosis, in different developmental, geographical, societal, and cultural contexts.

Applications are invited for research studies to produce new, actionable evidence to help medical, social, and public health systems work together to address structural barriers to health and health equity, including racism and the social conditions that impact health.

Grants will be awarded to support projects that focus on addressing knowledge and practice gaps related to the utilization and optimization of telemedicine/telehealth in the care of patients with rheumatological conditions. Pfizer is particularly interested in programs that focus on any or all the following areas of need: